These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 6999652)
1. Prolongation of heterotopic cardiac allografts in rats by cyclosporin A. Kawahara K; Sutherland DE; Rynasiewicz JJ; Najarian JS Surgery; 1980 Oct; 88(4):594-600. PubMed ID: 6999652 [TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A for immunosuppression: observations in rat heart, pancreas, and islet allograft models and in human renal and pancreas transplantation. Rynasiewicz JJ; Sutherland DE; Ferguson RM; Squifflet JP; Morrow CE; Goetz FC; Najarian JS Diabetes; 1982 Aug; 31 Suppl 4():92-108. PubMed ID: 6819969 [TBL] [Abstract][Full Text] [Related]
3. Survival of cardiac allografts in rats treated with cyclosporin A. Jamieson SW; Burton NA; Bieber CP; Reitz BA; Oyer PE; Stinson EB; Shumway NE Surg Forum; 1979; 30():289-91. PubMed ID: 395684 [No Abstract] [Full Text] [Related]
4. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection. Zuo Z; Wang C; Carpenter D; Okada Y; Nicolaidou E; Toyoda M; Trento A; Jordan SC Transplantation; 2001 Mar; 71(5):686-91. PubMed ID: 11292303 [TBL] [Abstract][Full Text] [Related]
5. The immunopharmacology of immunosuppression by 15-deoxyspergualin. Yuh DD; Morris RE Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226 [TBL] [Abstract][Full Text] [Related]
6. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Koskinen PK; Lemström KB; Häyry PJ Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive effects of the cyclosporin derivative SDZ IMM 125 on kidney allograft in the dog and small bowel and pancreas allografts in the rat. Chen H; Qi S; Xu D; Bergeron E; Wu J; Beauregard-Zollinger L; Tan A; Daloze P Clin Immunol Immunopathol; 1996 Jul; 80(1):76-81. PubMed ID: 8674242 [TBL] [Abstract][Full Text] [Related]
8. Evidence that LS-2616 (linomide) causes acute rejection of rat allografts protected by cyclosporine but not of long-term surviving allografts. Wanders A; Vogt P; Karlsson-Parra A; Wonigkeit K; Gerdin B; Tufveson G Transplantation; 1991 Aug; 52(2):234-8. PubMed ID: 1871795 [TBL] [Abstract][Full Text] [Related]
9. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice. Gao L; Woo J; Buelow R J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086 [TBL] [Abstract][Full Text] [Related]
10. 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts. Redaelli CA; Wagner M; Tien YH; Mazzucchelli L; Stahel PF; Schilling MK; Dufour JF Hepatology; 2001 Nov; 34(5):926-34. PubMed ID: 11679963 [TBL] [Abstract][Full Text] [Related]
11. Prolongation of cardiac xenograft survival in rats receiving cyclosporin A. Homan WP; Williams KA; Fabre JW; Millard PR; Morris PJ Transplantation; 1981 Mar; 31(3):164-6. PubMed ID: 7015610 [TBL] [Abstract][Full Text] [Related]
12. 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants. Redaelli CA; Wagner M; Günter-Duwe D; Tian YH; Stahel PF; Mazzucchelli L; Schmid RA; Schilling MK Kidney Int; 2002 Jan; 61(1):288-96. PubMed ID: 11786111 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine. Stoltenberg RL; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW Transplantation; 1995 Nov; 60(9):993-8. PubMed ID: 7491707 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of endothelin-1 improves survival and vasculopathy in rat cardiac transplants treated with cyclosporine. Simonson MS; Robinson AV; Schulak JA; Hricik DE Transplantation; 2002 Apr; 73(7):1054-9. PubMed ID: 11965031 [TBL] [Abstract][Full Text] [Related]
15. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts. den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200 [TBL] [Abstract][Full Text] [Related]
16. Prolonged allograft survival with niridazole, azathioprine, and prednisolone. Salaman JR; Bird M; Godfrey AM; Jones B; Millar D; Miller J Transplantation; 1977 Jan; 23(1):29-32. PubMed ID: 319573 [TBL] [Abstract][Full Text] [Related]
17. The effects of cyclosporine on varying segments of small-bowel grafts in the rat. Kimura K; Money SR; Jaffe BM Surgery; 1988 Jul; 104(1):64-9. PubMed ID: 3260410 [TBL] [Abstract][Full Text] [Related]
18. Studies on the immunosuppressive properties of cyclosporin a in rats receiving renal allografts. Homan WP; Fabre JW; Williams KA; Millard PR; Morris PJ Transplantation; 1980 May; 29(5):361-6. PubMed ID: 6990560 [TBL] [Abstract][Full Text] [Related]
19. Comparison of cyclosporin A and G with and without azathioprine regarding immunosuppressive efficacy, toxicity, and pharmacokinetics in Lewis rats. Hagberg RC; Hoyt EG; Billingham ME; Sibley RK; Starnes VA; Baldwin JC J Heart Transplant; 1988; 7(5):359-69. PubMed ID: 3058906 [TBL] [Abstract][Full Text] [Related]
20. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]